Xindao Biotech

Xindao Biotech is a Suzhou-based biotechnology company specializing in the development of next-generation single-molecule protein sequencing technology. The company leverages nanopore-based sensing and advanced biochemical techniques to enable high-throughput, high-sensitivity detection of protein sequences and post-translational modifications. By providing a comprehensive platform for proteomics, Xindao Biotech aims to accelerate drug discovery, biomarker identification, and clinical diagnostics. Its technology addresses the limitations of traditional mass spectrometry and antibody-based methods, offering a more direct and scalable approach to understanding the proteome.